vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Iron Mountain (IRM). Click either name above to swap in a different company.

Iron Mountain is the larger business by last-quarter revenue ($1.8B vs $950.5M, roughly 1.9× Astrana Health, Inc.). Iron Mountain runs the higher net margin — 5.1% vs 0.7%, a 4.4% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 16.6%). Astrana Health, Inc. produced more free cash flow last quarter ($-6.0M vs $-16.2M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 11.7%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Iron Mountain Inc. is an American enterprise information management services company founded in 1951 and headquartered in Portsmouth, New Hampshire. Its records management, information destruction, and data backup and recovery services are supplied to more than 220,000 customers in 58 countries throughout North America, Europe, Latin America, Africa, Asia, and Oceania.

ASTH vs IRM — Head-to-Head

Bigger by revenue
IRM
IRM
1.9× larger
IRM
$1.8B
$950.5M
ASTH
Growing faster (revenue YoY)
ASTH
ASTH
+26.3% gap
ASTH
42.9%
16.6%
IRM
Higher net margin
IRM
IRM
4.4% more per $
IRM
5.1%
0.7%
ASTH
More free cash flow
ASTH
ASTH
$10.3M more FCF
ASTH
$-6.0M
$-16.2M
IRM
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
11.7%
IRM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASTH
ASTH
IRM
IRM
Revenue
$950.5M
$1.8B
Net Profit
$6.6M
$93.1M
Gross Margin
Operating Margin
1.9%
18.5%
Net Margin
0.7%
5.1%
Revenue YoY
42.9%
16.6%
Net Profit YoY
184.4%
-11.9%
EPS (diluted)
$0.12
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
IRM
IRM
Q4 25
$950.5M
$1.8B
Q3 25
$956.0M
$1.8B
Q2 25
$654.8M
$1.7B
Q1 25
$620.4M
$1.6B
Q4 24
$665.2M
$1.6B
Q3 24
$478.7M
$1.6B
Q2 24
$486.3M
$1.5B
Q1 24
$404.4M
$1.5B
Net Profit
ASTH
ASTH
IRM
IRM
Q4 25
$6.6M
$93.1M
Q3 25
$373.0K
$86.2M
Q2 25
$9.4M
$-43.3M
Q1 25
$6.7M
$16.2M
Q4 24
$-7.8M
$105.7M
Q3 24
$16.1M
$-33.7M
Q2 24
$19.2M
$34.6M
Q1 24
$14.8M
$77.0M
Operating Margin
ASTH
ASTH
IRM
IRM
Q4 25
1.9%
18.5%
Q3 25
2.0%
17.6%
Q2 25
3.1%
15.2%
Q1 25
3.3%
16.0%
Q4 24
0.1%
17.9%
Q3 24
5.9%
16.1%
Q2 24
6.2%
15.0%
Q1 24
7.5%
16.6%
Net Margin
ASTH
ASTH
IRM
IRM
Q4 25
0.7%
5.1%
Q3 25
0.0%
4.9%
Q2 25
1.4%
-2.5%
Q1 25
1.1%
1.0%
Q4 24
-1.2%
6.7%
Q3 24
3.4%
-2.2%
Q2 24
3.9%
2.3%
Q1 24
3.7%
5.2%
EPS (diluted)
ASTH
ASTH
IRM
IRM
Q4 25
$0.12
$0.31
Q3 25
$0.01
$0.28
Q2 25
$0.19
$-0.15
Q1 25
$0.14
$0.05
Q4 24
$-0.14
$0.35
Q3 24
$0.33
$-0.11
Q2 24
$0.40
$0.12
Q1 24
$0.31
$0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
IRM
IRM
Cash + ST InvestmentsLiquidity on hand
$429.5M
$158.5M
Total DebtLower is stronger
$16.2B
Stockholders' EquityBook value
$779.3M
$-981.0M
Total Assets
$2.2B
$21.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
IRM
IRM
Q4 25
$429.5M
$158.5M
Q3 25
$463.4M
Q2 25
$342.1M
Q1 25
$260.9M
Q4 24
$290.8M
$155.7M
Q3 24
$350.3M
Q2 24
$327.7M
Q1 24
$337.3M
Total Debt
ASTH
ASTH
IRM
IRM
Q4 25
$16.2B
Q3 25
$15.5B
Q2 25
$14.8B
Q1 25
$14.2B
Q4 24
$13.0B
Q3 24
$13.2B
Q2 24
$12.8B
Q1 24
$12.6B
Stockholders' Equity
ASTH
ASTH
IRM
IRM
Q4 25
$779.3M
$-981.0M
Q3 25
$775.5M
$-882.0M
Q2 25
$765.5M
$-767.4M
Q1 25
$745.4M
$-698.5M
Q4 24
$712.7M
$-503.1M
Q3 24
$704.6M
$-259.0M
Q2 24
$678.9M
$-132.9M
Q1 24
$653.5M
$18.5M
Total Assets
ASTH
ASTH
IRM
IRM
Q4 25
$2.2B
$21.1B
Q3 25
$2.2B
$20.6B
Q2 25
$1.4B
$20.2B
Q1 25
$1.3B
$19.4B
Q4 24
$1.4B
$18.7B
Q3 24
$1.3B
$18.5B
Q2 24
$1.3B
$18.0B
Q1 24
$1.2B
$17.8B
Debt / Equity
ASTH
ASTH
IRM
IRM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
679.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
IRM
IRM
Operating Cash FlowLast quarter
$-2.9M
$500.0M
Free Cash FlowOCF − Capex
$-6.0M
$-16.2M
FCF MarginFCF / Revenue
-0.6%
-0.9%
Capex IntensityCapex / Revenue
0.3%
28.0%
Cash ConversionOCF / Net Profit
-0.44×
5.37×
TTM Free Cash FlowTrailing 4 quarters
$104.5M
$-931.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
IRM
IRM
Q4 25
$-2.9M
$500.0M
Q3 25
$10.0M
$267.6M
Q2 25
$90.9M
$375.1M
Q1 25
$16.6M
$197.3M
Q4 24
$-10.9M
$431.6M
Q3 24
$34.0M
$252.9M
Q2 24
$23.2M
$382.2M
Q1 24
$6.0M
$130.0M
Free Cash Flow
ASTH
ASTH
IRM
IRM
Q4 25
$-6.0M
$-16.2M
Q3 25
$7.4M
$-256.3M
Q2 25
$89.5M
$-181.6M
Q1 25
$13.6M
$-477.5M
Q4 24
$-13.5M
$-186.0M
Q3 24
$31.7M
$-143.2M
Q2 24
$20.4M
$-14.6M
Q1 24
$5.6M
$-251.1M
FCF Margin
ASTH
ASTH
IRM
IRM
Q4 25
-0.6%
-0.9%
Q3 25
0.8%
-14.6%
Q2 25
13.7%
-10.6%
Q1 25
2.2%
-30.0%
Q4 24
-2.0%
-11.8%
Q3 24
6.6%
-9.2%
Q2 24
4.2%
-1.0%
Q1 24
1.4%
-17.0%
Capex Intensity
ASTH
ASTH
IRM
IRM
Q4 25
0.3%
28.0%
Q3 25
0.3%
29.9%
Q2 25
0.2%
32.5%
Q1 25
0.5%
42.4%
Q4 24
0.4%
39.1%
Q3 24
0.5%
25.4%
Q2 24
0.6%
25.9%
Q1 24
0.1%
25.8%
Cash Conversion
ASTH
ASTH
IRM
IRM
Q4 25
-0.44×
5.37×
Q3 25
26.69×
3.10×
Q2 25
9.65×
Q1 25
2.48×
12.15×
Q4 24
4.08×
Q3 24
2.11×
Q2 24
1.21×
11.04×
Q1 24
0.40×
1.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

IRM
IRM

Storage Rental$1.1B58%
Services$781.9M42%

Related Comparisons